The development and impact of tuberculosis vaccines.
Vaccination is expected to make a major contribution to the goal of eliminating tuberculosis worldwide by 2050. But developing a new effective vaccine will require innovation in scientific research, a proactive approach to clinical trials of new vaccine candidates, and application of vaccines as part of an integrated approach to disease control.
Young
Douglas
D
Imperial College, University of London, South Kensington Campus, London SW7 2AZ, United Kingdom. d.young@imperial.ac.uk
Dye
Christopher
C
D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D014943:Global Health; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D013678:Technology, Pharmaceutical; D014376:Tuberculosis / Q000453:epidemiology / Q000517:prevention & control*; D032581:Tuberculosis Vaccines / Q000276:immunology / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control; D017778:Vaccines, Combined
D001500:BCG Vaccine; D032581:Tuberculosis Vaccines; D017778:Vaccines, Combined